You have 9 free searches left this month | for more free features.

lucitanib

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor, Gynecologic Cancer Trial in Worldwide (Lucitanib, Nivolumab)

Suspended
  • Advanced Solid Tumor
  • Gynecologic Cancer
  • Los Angeles, California
  • +26 more
Dec 16, 2022

Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

Withdrawn
  • Carcinoma, Non-small Cell Lung Cancer
  • nivolumab
  • +5 more
  • Detroit, Michigan
  • +22 more
Mar 8, 2022

Breast Cancer, Metastatic Breast Cancer, MBC Trial in United States (Lucitanib)

Terminated
  • Breast Cancer
  • +7 more
  • Lucitanib
  • Sedona, Arizona
  • +32 more
Jun 20, 2020

Solid Tumors Trial in France, Italy, Spain (Lucitanib)

Completed
  • Solid Tumors
  • Lucitanib
  • Villejuif, Paris, France
  • +3 more
Jan 2, 2020

Breast Cancer Trial in Worldwide (lucitanib)

Completed
  • Breast Cancer
  • lucitanib
  • East Melbourne, Australia
  • +28 more
Jan 2, 2020

NSCLC, Squamous NSCLC, NSCLC Trial in Worldwide (Lucitanib)

Terminated
  • Non-Small Cell Lung Cancer
  • +8 more
  • Lucitanib
  • Los Angeles, California
  • +18 more
Jul 22, 2019

Advanced Cancer Trial in La Jolla (Lucitanib)

Withdrawn
  • Advanced Cancer
  • Lucitanib
  • La Jolla, California
    UC San Diego Moores Cancer Center
Jul 31, 2018

Advanced Solid Tumors Trial in Shanghai (Lucitanib)

Completed
  • Advanced Solid Tumors
  • Lucitanib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 14, 2017